# Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients

> **NCT00570011** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 112 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** Somatropin
- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT00570011
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-06
- **Primary completion:** —
- **Final completion:** 1998-12
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2007-12-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00570011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00570011, "Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00570011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*